Executive Vice President and Chief Financial Officer · HEALTHEQUITY, INC. (HQY)

Tyson Murdock

A named executive officer of HEALTHEQUITY in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$4,457,884

Salary $391,917Stock awards $3,702,566

FY2022: $2,704,539

4th of 6 named executive officers at Healthequity by FY2023 total.

6 named officers on file for HEALTHEQUITY, FY2023

Tyson Murdock’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • HQY’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how HEALTHEQUITY’s whole pay program stands against its peers

  • HEALTHEQUITY’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HQY→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 12, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Tyson Murdock’s full pay file as a PDF — free

More than this page: up to 10 years of Tyson’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Tyson Murdock compensation by year

HEALTHEQUITY Summary Compensation Table · all 2 fiscal years held
In US dollars, as HEALTHEQUITY reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$350,000$391,917
Bonus$0$0
Stock awards$2,146,989$3,702,566
Option awards$0$0
Non-equity incentive$196,875$352,726
Pension and deferred compensation$0$0
All other$10,675$10,675
Total$2,704,539$4,457,884

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: HEALTHEQUITY, INC. DEF 14A filed May 12, 2023, accession 0001104659-23-059479, and prior-year filings. Open the filing on EDGAR.

How this page was built: the HEALTHEQUITY, INC. filed document, accession 0001104659-23-059479. Every figure is read from that document and cited to the page and table it appears in. Filed May 12, 2023.

$2.7M
$4.5M
FY22
FY23
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
PSU40,892$2,488,278—
RSU20,446$1,244,139—
PSU17,413$1,059,581—
PSU7,261$441,832—
RSU6,918$420,960—
RSU6,529$397,290—
RSU1,698$103,323—

Per the Outstanding Equity Awards at Fiscal Year-End table in HEALTHEQUITY, INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

6 Form 4 lines since the FY2023 proxy (filed May 12, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2023-12-28Gift—1,538$0.0064,937
2023-12-11Gift—2,343$0.0066,475
2023-10-13Sale10b5-11,000$76.5568,818
2023-10-04Tax withholding—571$72.0669,818
2023-09-07Sale10b5-12,844$71.3570,389
2023-07-05Tax withholding—580$62.1873,233

The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments HEALTHEQUITY discloses, by trigger · FY2023
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$400,000—$25,606$778,332
Change in control and involuntary termination$400,000$5,026,879$25,606$5,805,211
Resignation for good reason, no change in control$400,000—$25,606$778,332
Disability$0—$0$352,726
Death$0—$0$352,726
Change in control and resignation for good reason$400,000$5,026,879$25,606$5,805,211

Per the Potential Payments Upon Termination or Change in Control table in HEALTHEQUITY, INC.'s FY2023 proxy. Estimates as the company printed them; a dash means it printed no figure.

HEALTHEQUITY’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Jon KesslerPresident & Chief Executive Officer$13,400,167
Elimelech RosnerExecutive Vice President and Chief Technology Officer$12,506,661
Edward BloombergFormer Executive Vice President and Chief Operating Officer$5,242,581
Tyson Murdock · this pageExecutive Vice President and Chief Financial Officer$4,457,884
Larry TrittschuhExecutive Vice President and Chief Security Officer$3,041,837
Stephen NeelemanFounder and Vice Chairman$2,790,191

The full HEALTHEQUITY compensation record

free company brief

This page is one person within HEALTHEQUITY's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the HEALTHEQUITY proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are HEALTHEQUITY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Tyson Murdock's compensation dossier · One-time report. No refunds.